secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-09-24T10:01:32+00:00
Accession:  0001193125-26-400087
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health issues 547,898 shares to cut $5.05M of 2025 Streeterville note
----------------------------------------------------------------------------

- Exchanged 547,898 common shares for $5,049,909 reduction in $10.81M secured note to Streeterville Capital.
- Shares issued under Section 3(a)(9); no cash paid, shares to become free-trading after Rule 144 holding period tacking.
- Post-exchange share count ~1,281,867; issuance adds ~74.6% to prior outstanding stock.
- Note reduction represents ~47% of original principal; remaining balance continues under existing terms.
- CEO Lisa Conte signed; Streeterville receives unrestricted shares via DWAC delivery.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526400087/0001193125-26-400087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526400087/d161376d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-400087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer